Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

F-Star Therapeutics Inc (FSTX)

F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 156,512
  • Shares Outstanding, K 21,982
  • Annual Sales, $ 21,170 K
  • Annual Income, $ -31,280 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.85
  • Price/Sales 7.16
  • Price/Cash Flow N/A
  • Price/Book 2.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.82
  • Most Recent Earnings $-0.84 on 11/10/22
  • Next Earnings Date 03/13/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.55
  • Number of Estimates 3
  • High Estimate -0.32
  • Low Estimate -0.67
  • Prior Year 0.47
  • Growth Rate Est. (year over year) -217.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.50 +58.22%
on 02/09/23
7.12 unch
on 03/08/23
+2.70 (+61.09%)
since 02/08/23
3-Month
2.99 +138.13%
on 01/26/23
7.12 unch
on 03/08/23
+1.80 (+33.83%)
since 12/08/22
52-Week
2.07 +243.96%
on 05/12/22
7.12 unch
on 03/08/23
+4.22 (+145.94%)
since 03/08/22

Most Recent Stories

More News
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.

invoX Pharma Limited (“invoX”) , a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline of innovative products, today...

FSTX : 7.12 (unch)
F-STAR THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

FSTX : 7.12 (unch)
F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

Previously announced agreement for F-star Therapeutics to be acquired by invoX Pharma; transaction expected to close in the second half of 2022 License...

FSTX : 7.12 (unch)
invoX Pharma Extends Tender Offer to Acquire F-star Therapeutics, Inc.

invoX Pharma Limited (“invoX”) , a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) , focused on research and development (R&D) and business development...

FSTX : 7.12 (unch)
SHAREHOLDER ALERT: Weiss Law Reminds FSTX, STCN, GRRB, and ZEN Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

FSTX : 7.12 (unch)
STCN : 10.34 (+3.99%)
ZEN : 77.48 (+0.03%)
F-star Therapeutics Announces a License Agreement with Takeda for a Novel Next-Generation Immuno-oncology Bispecific Antibody

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star”), operating...

FSTX : 7.12 (unch)
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of F-star Therapeutics, Inc. (NasdaqCM: FSTX)...

FSTX : 7.12 (unch)
FSTX STOCK ALERT: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of F-star Therapeutics, Inc. (NASDAQ: FSTX) to invoX Pharma for $7.12 per share is fair to F-star shareholders.

FSTX : 7.12 (unch)
SHAREHOLDER ALERT: Weiss Law Reminds FSTX, STCN, GRRB, and OBCI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

FSTX : 7.12 (unch)
STCN : 10.34 (+3.99%)
OBCI : 13.03 (-0.08%)
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates DRE, RDUS, FSTX, RADA, USAK

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DRE : 48.20 (+0.48%)
RDUS : 18.46 (+5.07%)
FSTX : 7.12 (unch)
RADA : 9.87 (-0.40%)
USAK : 31.71 (+0.03%)

Business Summary

F-star Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 7.13
2nd Resistance Point 7.13
1st Resistance Point 7.12
Last Price 7.12
1st Support Level 7.11
2nd Support Level 7.11
3rd Support Level 7.10

See More

52-Week High 7.12
Last Price 7.12
Fibonacci 61.8% 5.19
Fibonacci 50% 4.59
Fibonacci 38.2% 4.00
52-Week Low 2.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar